Alterity Therapeutics (ATHE) Skyrockets over 150% Following New Patent Approval
The new patent is Alterity’s next-generation drug development portfolio based on the treatment of neurodegenerative diseases. Alterity Therapeutics Ltd. (ATHE) stock kicked off in style